Abstract: The present invention relates to metal complexes and to electronic devices, in particular organic electroluminescent devices, comprising these metal complexes.
Type:
Grant
Filed:
May 30, 2012
Date of Patent:
June 6, 2017
Assignee:
Merck Patent GmbH
Inventors:
Philipp Stoessel, Anja Jatsch, Esther Breuning
Abstract: The invention relates to novel formulations comprising an organic semiconductor (OSC) and a conductive additive, to their use as conducting inks for the preparation of organic electronic (OE) devices, especially organic photovoltaic (OPV) cells, to methods for preparing OE devices using the novel formulations, and to OE devices and OPV cells prepared from such methods and formulations.
Type:
Grant
Filed:
September 19, 2008
Date of Patent:
June 6, 2017
Assignee:
MERCK PATENT GMBH
Inventors:
Mark James, Iain McCulloch, Warren Duffy, Philip Edward May, Dan Walker, David P. Waller, Richard Kendall Childers, Sheila E. Rodman
Abstract: The invention relates to novel conjugated polymers containing one or more repeating units derived from indacenodibenzothiophene or dithia-dicyclopenta-dibenzothiophene, to methods for their preparation and educts or intermediates used therein, to polymer blends, mixtures and formulations containing them, to the use of the polymers, polymer blends, mixtures and formulations as organic semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices, and to OE and OPV devices comprising these polymers, polymer blends, mixtures or formulations.
Type:
Grant
Filed:
April 2, 2013
Date of Patent:
June 6, 2017
Assignee:
Merck Patent GmbH
Inventors:
William Mitchell, Mansoor D'Lavari, Changsheng Wang, Steven Tierney, Jingyao Song
Abstract: Compounds of the formula I in which R1, R4, R6, R, X1, X2, X3, X4, q and W have the meanings indicated in claim 1, are inhibitors of fatty acid synthase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
Type:
Grant
Filed:
May 9, 2014
Date of Patent:
June 6, 2017
Assignee:
Merck Patent GmbH
Inventors:
Christos Tsaklakidis, Wolfgang Staehle, Birgitta Leuthner, Paul Czodrowski, Thomas Fuchss
Abstract: The present invention relates to microspheres and to the use thereof, preferably as laser-absorbing additive, and to a process for the production thereof.
Abstract: The invention relates to a method of preparing a polymer film and to the use of such polymer film as in liquid crystal displays (LCDs) or other optical or electro optical devices, for decorative or security applications, as alignment layer or optical retardation film.
Type:
Grant
Filed:
October 1, 2014
Date of Patent:
May 30, 2017
Assignee:
Merck Patent GmbH
Inventors:
Graham Smith, Owain Llyr Parri, Sarah Whitehouse, Tara Perrett
Abstract: The present invention relates to compounds of the formula (I) and in particular to medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of osteoarthritis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.
Abstract: The invention provides novel heterocyclic amine compounds according to Formula (I) and their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
Type:
Grant
Filed:
March 3, 2016
Date of Patent:
May 30, 2017
Assignee:
Merck Patent GmbH
Inventors:
Ruoxi Lan, Bayard R. Huck, Xiaoling Chen, Lizbeth C. Deselm, Hui Qiu, Yufang Xiao, Constantin Neagu, Igor Mochalkin, Theresa L. Johnson
Abstract: The present invention relates to formula, comprising at least one solvent, and at least one functional composition of the general formula (I), wherein A is a functional structural element, B is a solvent-providing structural element, and k is an integer in the range of 1 to 20. The molecular weight of the functional composition is at least 550 g/mol, and the solvent-providing structural element B corresponds to the general formula ((L-I). Ar1, Ar2 JeWeUs, independently of each other, signify an aryl or heteroaryl group, which can be substituted with one or several discretionary residues R. Each X is, independently of one another, N or CR2, preferably CH.
Type:
Grant
Filed:
September 15, 2010
Date of Patent:
May 30, 2017
Assignee:
Merck Patent GmbH
Inventors:
Rémi Manouk Anémian, Susanne Heun, Thomas Eberle, Philipp Stoessel
Abstract: The present invention relates to five-layered pigments based on multi-coated platelet-shaped substrates which comprise a layer sequence comprising (A) a layer of SnO2 having a layer thickness of 0.1-50 nm, (B) a high-refractive-index coating consisting of TiO2 in the rutile modification having a layer thickness of 10-800 nm, (C) a colorless coating having a refractive index n?1.8 having a layer thickness of 20-800 nm, (D) a high-refractive-index coating consisting of SnO2 having a layer thickness of 0.1-50 nm, (E) a layer of TiO2 in the rutile modification having a layer thickness of 10-800 nm, and optionally (F) an outer protective layer, and to the use thereof in paints, coatings, powder coatings, printing inks, security printing inks, plastics, ceramic materials, glasses, as dopants for the laser marking of papers and plastics, in cosmetic formulations and for the preparation of pigment preparations and dry preparations.
Type:
Application
Filed:
February 8, 2017
Publication date:
May 25, 2017
Applicant:
MERCK PATENT GMBH
Inventors:
Christoph SCHMIDT, Andrea HEYLAND, Sabine SCHOEN, Veronika HOCHSTEIN, Uta HENSEN
Abstract: A compound of formula (I) is provided: wherein R1, R2, R3, R4, L and Z have the meaning given in the claims. Further provided is the prophylaxis and treatment of diseases with the compound of formula (I).
Abstract: The present invention is directed to nanoparticles comprising chitosan and an antigen, whereby the chitosan has a degree of deacetylation of about 90% and a molecular weight from 5 kDa to 80 kDa, to microparticles containing such nanoparticles as well as to a process for preparation of such particles. The particles are usable for vaccination.
Type:
Application
Filed:
May 12, 2015
Publication date:
May 25, 2017
Applicant:
MERCK PATENT GMBH
Inventors:
Andrea HANEFELD, Markus WEIGANDT, Michael WOLF, Percy KNOLLE, Matthias SCHROEDER, Regina SCHERLIESS, Peter WALDEN, Andrea DIEDRICH, Hartwig STECKEL, Renato Brito BALEEIRO
Abstract: The present invention relates to compounds of the formula I and in particular medicaments comprising at least one compound of the formula I for use in the treatment and/or prophylaxis of physiological and/or pathophysiological states in the triggering of which ADAMTS5 is involved, in particular for use in the treatment and/or prophylaxis of osteoarthritis, hepatocirrhosis, traumatic cartilage injuries, pain, allodynia or hyperalgesia.
Abstract: The present invention is related to brilliant black pigments comprising a flaky aluminum oxide substrate having a coating comprising a layered structure composed of a hematite and a magnetite layer, to a process for the production of said pigments, as well as to their use.
Abstract: The invention relates to the use of specific glucuronolactone derivatives as self-tanning substances, as tanning enhancers for dihydroxyacetone or for a mixture of self-tanning substances comprising dihydroxyacetone, for modulation of the hue achieved in the case of tanning with dihydroxyacetone or by the mixture or preparation comprising dihydroxyacetone, as contrast-reduction agents or for coloring keratin-containing fibers, and to preparations or compositions for coloring keratin-containing fibers comprising these specific glucuronolactone derivatives.
Type:
Grant
Filed:
January 30, 2014
Date of Patent:
May 23, 2017
Assignee:
Merck Patent GmbH
Inventors:
Christophe Carola, Rene Peter Scheurich
Abstract: The present invention relates to Eu—, Sm— or Pr-doped silicate compounds, to a process for the preparation thereof and to the use thereof as conversion phosphors. The present invention also relates to an emission-converting material comprising at least the conversion phosphor according to the invention and to the use thereof in light sources, in particular pc-LEDs (phosphor converted light emitting devices). The present invention furthermore relates to light sources, in particular pc-LEDs, and lighting units which contain a primary light source and the emission-converting material according to the invention.
Type:
Grant
Filed:
March 22, 2013
Date of Patent:
May 23, 2017
Assignee:
MERCK PATENT GMBH
Inventors:
Holger Winkler, Thomas Juestel, Arturas Katelnikovas, Florian Baur
Abstract: The present invention relates to liquid-crystalline media comprising at least one compound of the formula I and at least one compound of the formula II or at least one compound of the formula I and at least one compound of the formula III or at least one compound of the formula II and at least one compound of the formula III or at least one compound of the formula I and at least one compound of the formula II and at least one compound of the formula III: in which the parameters have the meaning indicated in Claim 1, and to components comprising these media for high-frequency technology, in particular phase shifters and microwave array antennas.
Type:
Grant
Filed:
June 29, 2010
Date of Patent:
May 23, 2017
Assignee:
Merck Patent GMBH
Inventors:
Atsutaka Manabe, Mark Goebel, Elvira Montenegro
Abstract: The invention relates to metal complexes and to electronic devices, in particular organic electroluminescence devices, containing said metal complexes.
Type:
Application
Filed:
June 3, 2015
Publication date:
May 18, 2017
Applicant:
Merck Patent GmbH
Inventors:
Nils Koenen, Anna Hayer, Holger Heil, Philipp Stoessel
Abstract: The present invention provides compounds of Formula (i). Furthermore, pharmaceutical compositions are provided comprising at least one compound of Formula (i), for the treatment of parasitic diseases including malaria, as well as neurodegenerative diseases.
Abstract: The invention relates to a polymer film having negative optical dispersion, novel polymerisable compounds and liquid crystal (LC) materials for its preparation, and the use of the polymer film and novel compounds and materials in optical, electrooptical, electronic, semiconducting or luminescent components or devices.
Type:
Grant
Filed:
October 15, 2014
Date of Patent:
June 6, 2017
Assignee:
MERCK PATENT GMBH
Inventors:
Owain Llyr Parri, Kevin Adlem, Karl Skjonnemand, David Wilkes